# OnCo record paper-checkmate-227-n-engl-j-med-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-227-n-engl-j-med-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-227-n-engl-j-med-2018" ;
  schema:name "Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden"@en ;
  schema:description "Published report from the CheckMate 227 trial registered as NCT02477826, in New England Journal of Medicine (2018), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-227-n-engl-j-med-2018/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1801946>, <https://pubmed.ncbi.nlm.nih.gov/29658845/>, <https://europepmc.org/article/MED/29658845>, <https://clinicaltrials.gov/study/NCT02477826> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1801946> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Hellmann MD, Ciuleanu TE, Pluzanski A, et al." ;
  onco:trials <https://onco.cc/trials/checkmate-227/> ;
  onco:journals <https://onco.cc/journals/nejm/> .